Pharmacokinetic and other drug interactions in patients with AIDS

被引:38
作者
Dasgupta, A
Okhuysen, PC
机构
[1] Univ Texas, Houston Med Sch, Dept Pathol & Lab Med, Houston, TX 77030 USA
[2] Univ Texas, Houston Med Sch, Div Infect Dis, Houston, TX 77030 USA
关键词
AIDS; drug interactions; drug monitoring;
D O I
10.1097/00007691-200112000-00001
中图分类号
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号
1001 ;
摘要
A variety of medications are used in treating patients infected with the human immunodeficiency virus (HIV). These medications are used to control viremia and to prevent and treat opportunistic infections. An individual is often required to take numerous drugs at the same time and thus clinicians are confronted with potential drug interactions, some of which are significant. Three different groups of anti-HIV drugs are used to treat patients. These groups include nucleoside reverse transcription inhibitors, non-nucleoside reverse transcription inhibitors, and protease inhibitors. This article reviews the most relevant drug interactions that occur during the treatment of HIV-infected patients with traditional and also alternative drugs. The role of therapeutic drug monitoring in the routine management of HIV-infected patients is discussed.
引用
收藏
页码:591 / 605
页数:15
相关论文
共 110 条
[1]  
AUGUST EM, 1991, MOL PHARMACOL, V39, P246
[2]   Determination of twelve antiretroviral agents in human plasma sample using reversed-phase high-performance liquid chromatography [J].
Aymard, G ;
Legrand, M ;
Trichereau, N ;
Diquet, B .
JOURNAL OF CHROMATOGRAPHY B-ANALYTICAL TECHNOLOGIES IN THE BIOMEDICAL AND LIFE SCIENCES, 2000, 744 (02) :227-240
[3]   Therapeutic drug monitoring of antiretrovirals in human immunodeficiency virus infection [J].
Back, DJ ;
Khoo, SH ;
Gibbons, SE ;
Barry, MG ;
Merry, C .
THERAPEUTIC DRUG MONITORING, 2000, 22 (01) :122-126
[4]  
Barry MG, 1998, BRIT J CLIN PHARMACO, V45, P501
[5]  
Beauverie P, 1998, AIDS, V12, P2510
[6]  
BLUM MR, 1988, AM J MED, V85, P189
[7]   EFFECT OF FLUCONAZOLE ON THE DISPOSITION OF PHENYTOIN [J].
BLUM, RA ;
WILTON, JH ;
HILLIGOSS, DM ;
GARDNER, MJ ;
HENRY, EB ;
HARRISON, NJ ;
SCHENTAG, JJ .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1991, 49 (04) :420-425
[8]   DIDEOXYCYTIDINE (DDC) - A POTENT ANTIRETROVIRAL AGENT FOR HUMAN-IMMUNODEFICIENCY-VIRUS INFECTION - AN INTRODUCTION [J].
BRODER, S .
AMERICAN JOURNAL OF MEDICINE, 1990, 88 (5B) :S1-S1
[9]  
Burger DM, 1998, ANTIVIR THER, V3, P215
[10]   THERAPEUTIC DRUG-MONITORING OF PHENYTOIN IN PATIENTS WITH THE ACQUIRED-IMMUNODEFICIENCY-SYNDROME [J].
BURGER, DM ;
MEENHORST, PL ;
MULDER, JW ;
KRAAIJEVELD, CL ;
KOKS, CHW ;
BULT, A ;
BEIJNEN, JH .
THERAPEUTIC DRUG MONITORING, 1994, 16 (06) :616-620